What the research found

Researchers analysed blood samples from over 13,000 US women to look for associations between sex hormone levels and markers of autoimmune activity. They measured 13 different autoimmune antibodies (including those linked to lupus and rheumatoid arthritis) alongside 11 female sex hormones, comparing women who tested positive for autoimmune antibodies with matched controls who did not.

The main finding was surprising in its restraint: most sex hormones showed no meaningful difference between women with detectable autoimmune antibodies and those without, whether before or after menopause. The one exception was DHEA-S (dehydroepiandrosterone sulphate), which did differ between the two groups, though the source doesn't specify the direction or magnitude of that difference.

Why it matters for you

If you're a woman tracking hormonal biomarkers—whether oestrogen, testosterone, or DHEA—this work suggests that autoimmune antibody status is not strongly reflected in routine sex hormone levels for most people. This means a normal hormone panel doesn't rule out underlying autoimmune processes, and conversely, managing sex hormones alone is unlikely to resolve autoimmune serology.

DHEA-S is an exception worth noting. It's a precursor hormone that some biohackers supplement with, and it does show a relationship to autoimmune markers. If you have a known autoimmune condition and are considering DHEA supplementation, this hints that your baseline DHEA-S level might warrant closer attention—though this study doesn't clarify whether the difference is protective, risk-increasing, or simply correlational.

The finding also underscores that autoimmune processes and sex hormone fluctuation (particularly around menopause) may operate somewhat independently from a biomarker perspective, even though clinically they often co-occur.

Caveats

• Observational, retrospective design: Blood samples were collected for clinical reasons; no interventions or follow-up were performed
• Cross-sectional snapshot: Hormone and antibody levels measured at a single timepoint, not tracked over time
• Limited mechanistic insight: The study reports associations but doesn't explain why DHEA-S differs or what that difference means clinically
• No information on effect size: The source doesn't quantify how large the DHEA-S difference actually is
• Autoimmune serology ≠ autoimmune disease: Testing positive for autoimmune antibodies doesn't necessarily mean active disease or symptoms